What is Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)? BIA-ALCL is not breast cancer—it is a type of non-Hodgkin’s lymphoma (cancer of the immune system). 

According to the U.S. Food and Drug Administration (FDA), as of August 2018 more than 230 people in the U.S. and 570 people worldwide have been diagnosed with Breast Implant Associated Anaplastic Large Cell Lymphoma.

The FDA classifies BIA-ALCL as an uncommon cancer.  The organization believes that women with textured breast implants have a small but increased risk of developing this disease in the tissue capsule the body forms around an implant over time. 

Things to Know
Advocacy
BIA-ALCL Ribbon
BIA-ALCL News Coverage